**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Alexander Graham Bell Association for the Deaf, Inc.
Address:
3417 Volta Place, NW
Washington, D.C. 20007-2778
United States
Phone: 202-337-5220
Fax: 202-337-8314
800 Number: 866-337-5220
TDD: --
Email Address: info@agbell.org
The Alexander Graham Bell Association for the Deaf, Inc., is a not-for-profit organization dedicated to helping hearing-impaired individuals by developing maximal use of residual hearing, speech reading, and speech and language skills. It strives to promote better public understanding of hearing loss. The association advocates the detection of hearing loss in early infancy as well as appropriate hearing aid use. It also collaborates on research relating to auditory or verbal communication. Established in 1890 by Alexander Graham Bell, the organization is also committed to working for better educational opportunities for affected children; providing in-service training for teachers; and offering scholarships. In addition, the association disseminates information on the causes of hearing impairment and options for remedial treatment. It collaborates with physicians, audiologists, speech/language specialists, and educators to promote educational, vocational, and social opportunities for affected individuals. The organization also supports legislation beneficial to affected individuals, conducts international conferences, and has one of the world's largest historical collections of information on deafness.
Chapters: 26
Website: http://www.agbell.org
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.